Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The path to cheaper and safer drugs: revamping the pharmaceutical industry in light of GlaxosmithKline's settlement.

The path to cheaper and safer drugs: revamping the pharmaceutical industry in light of GlaxosmithKline's settlement. J Law Med Ethics. 2005; 33(1):174-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.